AngioDynamics, Inc. (ANGO) vs Fulgent Genetics, Inc. (FLGT)

A side-by-side comparison of AngioDynamics, Inc. and Fulgent Genetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ANGO vs FLGT

growth of $100 · dividends reinvested · last 10y
ANGO -11.4% (-1.2%/yr)FLGT +130.1% (+8.7%/yr)FLGT compounded faster over this window
05001k2kStart $10020182020202220242026$89$230
ANGO FLGT

ANGO vs FLGT: by the numbers

  • •ANGO is the larger company ($596M vs $588M market cap).
  • •Both run net losses; ANGO's is the smaller (-11.48% vs -26.05% net margin).
  • •ANGO grew revenue faster over the past five years (1.93% vs -18.66% CAGR).

Metrics side by side

Valuation

MetricANGOFLGT
P/S ratio1.861.81
P/B ratio3.490.59
FCF yield0.09%N/A

Profitability

MetricANGOFLGT
Gross margin54.62%35.58%
Operating margin-12.47%-28.23%
Net margin-11.48%-26.05%
ROE-21.51%-8.42%
ROIC-20.75%-11.80%

Growth (annualized)

MetricANGOFLGT
Revenue CAGR (5Y)1.93%-18.66%
FCF CAGR (5Y)-51.49%N/A
Total return CAGR (5Y)-10.80%-22.38%

Frequently asked

Which has grown faster, ANGO or FLGT?
Over the past five years, ANGO grew revenue faster — ANGO at a 1.93% CAGR versus FLGT at -18.66%.
How have ANGO and FLGT total returns compared?
Over the past 10 years, ANGO delivered -0.58% and FLGT delivered 8.90% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.